Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384071132> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4384071132 abstract "Sudden cardiac death (SCD) from ventricular tachycardia/fibrillation (VT/VF) are a leading cause of death, but current therapies are limited. Despite extensive research on drugs targeting sarcolemmal ion channels, none have proven sufficiently effective for preventing SCD. Sarcoplasmic ryanodine receptor 2 (RyR2) Ca2+ release channels, the downstream effectors of sarcolemmal ion channels, are underexplored in this context. Recent evidence implicates reactive oxygen species (ROS)-mediated oxidation and hyperactivity of RyR2s in the pathophysiology of SCD. To test the hypothesis that RyR2 inhibition of failing arrhythmogenic hearts reduces sarcoplasmic Ca2+ leak and repolarization lability, mitigates VT/VF/SCD and improves contractile function. We used a guinea pig model that replicates key clinical aspects of human nonischemic HF, such as a prolonged QT interval, a high prevalence of spontaneous arrhythmic SCD, and profound Ca2+ leak via a hyperactive RyR2. HF animals were randomized to receive dantrolene (DS) or placebo in early or chronic HF. We assessed the incidence of VT/VF and SCD (primary outcome), ECG heart rate and QT variability, echocardiographic left ventricular (LV) structure and function, immunohistochemical LV fibrosis, and sarcoplasmic RyR2 oxidation. DS treatment prevented VT/VF and SCD by decreasing dispersion of repolarization and ventricular arrhythmias. Compared to placebo, DS lowered resting heart rate, preserved chronotropic competency during transient β-adrenergic challenge, and improved heart rate variability and cardiac function. Inhibition of RyR2 hyperactivity with dantrolene mitigates the vicious cycle of sarcoplasmic Ca2+ leak-induced increases in diastolic Ca2+ and ROS-mediated RyR2 oxidation, thereby increasing repolarization reserve and protecting against VT/VF/SCD. Moreover, the consequent increase in sarcoplasmic Ca2+ load improves contractile function. These potentially life-saving effects of RyR2 inhibition warrant further investigation, such as clinical studies of repurposing dantrolene as a potential new therapy for heart failure and/or SCD." @default.
- W4384071132 created "2023-07-13" @default.
- W4384071132 creator A5020769812 @default.
- W4384071132 creator A5021488135 @default.
- W4384071132 creator A5040823719 @default.
- W4384071132 creator A5064477997 @default.
- W4384071132 creator A5078616270 @default.
- W4384071132 date "2023-07-12" @default.
- W4384071132 modified "2023-10-02" @default.
- W4384071132 title "Ryanodine receptor 2 inhibition improves cardiac repolarization reserve and contractile function and prevents sudden arrhythmic death in failing hearts" @default.
- W4384071132 doi "https://doi.org/10.7554/elife.88638" @default.
- W4384071132 hasPublicationYear "2023" @default.
- W4384071132 type Work @default.
- W4384071132 citedByCount "0" @default.
- W4384071132 crossrefType "posted-content" @default.
- W4384071132 hasAuthorship W4384071132A5020769812 @default.
- W4384071132 hasAuthorship W4384071132A5021488135 @default.
- W4384071132 hasAuthorship W4384071132A5040823719 @default.
- W4384071132 hasAuthorship W4384071132A5064477997 @default.
- W4384071132 hasAuthorship W4384071132A5078616270 @default.
- W4384071132 hasBestOaLocation W43840711321 @default.
- W4384071132 hasConcept C113217602 @default.
- W4384071132 hasConcept C126322002 @default.
- W4384071132 hasConcept C146403970 @default.
- W4384071132 hasConcept C155730078 @default.
- W4384071132 hasConcept C164705383 @default.
- W4384071132 hasConcept C185263204 @default.
- W4384071132 hasConcept C190712762 @default.
- W4384071132 hasConcept C2775935837 @default.
- W4384071132 hasConcept C2776331378 @default.
- W4384071132 hasConcept C2778178275 @default.
- W4384071132 hasConcept C2778198053 @default.
- W4384071132 hasConcept C2781005686 @default.
- W4384071132 hasConcept C2993353509 @default.
- W4384071132 hasConcept C519063684 @default.
- W4384071132 hasConcept C71924100 @default.
- W4384071132 hasConceptScore W4384071132C113217602 @default.
- W4384071132 hasConceptScore W4384071132C126322002 @default.
- W4384071132 hasConceptScore W4384071132C146403970 @default.
- W4384071132 hasConceptScore W4384071132C155730078 @default.
- W4384071132 hasConceptScore W4384071132C164705383 @default.
- W4384071132 hasConceptScore W4384071132C185263204 @default.
- W4384071132 hasConceptScore W4384071132C190712762 @default.
- W4384071132 hasConceptScore W4384071132C2775935837 @default.
- W4384071132 hasConceptScore W4384071132C2776331378 @default.
- W4384071132 hasConceptScore W4384071132C2778178275 @default.
- W4384071132 hasConceptScore W4384071132C2778198053 @default.
- W4384071132 hasConceptScore W4384071132C2781005686 @default.
- W4384071132 hasConceptScore W4384071132C2993353509 @default.
- W4384071132 hasConceptScore W4384071132C519063684 @default.
- W4384071132 hasConceptScore W4384071132C71924100 @default.
- W4384071132 hasLocation W43840711321 @default.
- W4384071132 hasLocation W43840711322 @default.
- W4384071132 hasOpenAccess W4384071132 @default.
- W4384071132 hasPrimaryLocation W43840711321 @default.
- W4384071132 hasRelatedWork W2117576954 @default.
- W4384071132 hasRelatedWork W2124941830 @default.
- W4384071132 hasRelatedWork W2294080086 @default.
- W4384071132 hasRelatedWork W2420071309 @default.
- W4384071132 hasRelatedWork W2559783075 @default.
- W4384071132 hasRelatedWork W2883009693 @default.
- W4384071132 hasRelatedWork W3004475016 @default.
- W4384071132 hasRelatedWork W3129419069 @default.
- W4384071132 hasRelatedWork W3160724356 @default.
- W4384071132 hasRelatedWork W4220962412 @default.
- W4384071132 isParatext "false" @default.
- W4384071132 isRetracted "false" @default.
- W4384071132 workType "article" @default.